Lymphoblastic Lymphoma

Lymphoblastic Lymphoma is an aggressive cancer that can affect either type of lymphocyte. It is most commonly found in T-cells (almost 90% of cases), but some types arise from immature B-cells.

Though this cancer is rare and accounts for only 2% of Non-Hodgkin’s diagnoses per year, it is very common in children. In fact, up to 30% of all childhood lymphomas diagnosed per year will be lymphoblastic lymphoma.

In most cases, lymphoblastic lymphoma progresses to Stage IV prior to diagnosis. Tumors in this stage have spread to the bone marrow, spleen, and central nervous system. Symptoms include swollen lymph nodes, fatigue, weight loss, and night sweats.

Diagnosis and Staging of Lymphoblastic Lymphoma

To accurately diagnose and stage this disease, doctors may use blood work and bone marrow or lymph node biopsies. By examining the biopsied tissue under a microscope, doctors can identify the mutations that cause lymphoblastic lymphoma and make an accurate diagnosis. To determine the spread and stage of the disease, doctors may also use chest X-rays, CT scans, PET scans, or ultrasounds. Staging is as follows:

Stage I
Involvement of one group of lymph nodes on one side of the diaphragm.
Stage II
Involvement of two groups of lymph nodes on the same side of the diaphragm.
Stage III
Lymph involvement on both sides of the diaphragm. This stage may also be marked by involvement of the lungs or a mass in the chest.
Stage IV
Marked by spread into the central nervous system and/or bone marrow.

Treatment

The most common treatment is chemotherapy. The CHOP regimen has been used with great success, as has a newer regimen called hyper-CVAD (cytoxan, vincristine, adriamycin, and dexamethasone).

In some cases, radiation therapy will be used with chemotherapy, though it is never used as a sole treatment.

Radioimmunotherapy is also being researched as a treatment.

Cancer Patients have more options through clinical studies. Follow this link to learn more about clinical study opportunities near you.

Related Articles

lymphoma roundup

More Articles

More Articles

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...